Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Spontaneous adverse drug reaction reports on patients with cirrhosis: analysis of the nature, quantity and quality of the reports

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Franz CC, Egger S, Born C, Bravo AER, Krähenbühl S (2012) Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis. Eur J Clin Pharmacol 68:179–188

  2. 2.

    Verbeeck RK (2008) Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 64:1147–1161

  3. 3.

    Laffi G, Daskalopoulos G, Kronborg I, Hsueh W, Gentilini P, Zipser RD (1986) Effects of sulindac and ibuprofen in patients with cirrhosis and ascites: an explanation for the renal-sparing effect of sulindac. Gastroenterology 90:182–187

  4. 4.

    Hawcutt DB, Russell N, Maqsood H, Kouranloo K, Gomberg S, Waitt C, Sharp A, Riordan A, Turner MA (2016) Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001–2010: content and utility analysis. Br J Clin Pharmacol 82:1601–1612

  5. 5.

    Carnovale C, Gentili M, Fortino I, Merlino L, Clementi E, Radice S, on behalf the ViGer Group (2016) The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme. Expert Opin Drug Saf 15:131–139

  6. 6.

    Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R (2015) Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’. Hepatology 62:1620–1622

  7. 7.

    Weersink RA, Bouma M, Burger DM, Drenth JPH, Harkes-Idzinga SF, Hunfeld NGM, Metselaar HJ, Monster-Simons MH, Taxis K, Borgsteede SD (2018) Evidence-based recommendations to improve the safe use of drugs in patients with liver cirrhosis. Drug Saf 41:603–613

Download references

Author information

Correspondence to R. A. Weersink.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Weersink, R.A., Taxis, K., van Puijenbroek, E.P. et al. Spontaneous adverse drug reaction reports on patients with cirrhosis: analysis of the nature, quantity and quality of the reports. Eur J Clin Pharmacol (2020). https://doi.org/10.1007/s00228-020-02845-9

Download citation